Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009

Elia M Pestana Knight1, Nicholas K Schiltz, Paul M Bakaki

  • 1Pediatric Epilepsy Section, Epilepsy Center, Cleveland Clinic Neurological Institute, Cleveland, Ohio, U.S.A.

Epilepsia
|January 30, 2015
PubMed

Insights

Pediatric epilepsy surgery rates increased significantly from 1997 to 2009. However, this vital treatment remains underutilized, with disparities noted in Black children and those with public insurance.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Public Health

Background:

  • Epilepsy surgery is a critical treatment for refractory pediatric epilepsy.
  • Understanding trends in pediatric epilepsy surgery is essential for improving access and outcomes.

Purpose of the Study:

  • To analyze national trends in the utilization of pediatric epilepsy surgery in the United States from 1997 to 2009.
  • To identify demographic and payer-related disparities in surgical treatment.

Main Methods:

  • A serial cross-sectional study using triennial data from the Kids' Inpatient Database (1997-2009).
  • Calculated rates of specific epilepsy surgeries (lobectomies, partial lobectomies, hemispherectomies).
  • Used Mann-Kendall trend test and multivariable regression to assess changes over time and influencing factors.

Main Results:

  • Pediatric epilepsy surgery rates increased significantly, from 0.85 to 1.44 per 1,000 children with epilepsy.
  • Increases were observed across all age, race, and sex groups, and payer types.
  • Surgery rates were lowest among Black children and those with public insurance, and overall utilization remained below 35% of estimated need.

Conclusions:

  • Pediatric epilepsy surgery utilization has risen, contrasting with adult trends.
  • Epilepsy surgery remains underutilized in the pediatric population.
  • Significant disparities persist for Black children and those with public insurance regarding access to epilepsy surgery.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
367
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
508
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
882